At Roche, patients are central to everything we do and we are committed to improving the lives of patients in New Zealand. We contribute to this by developing and enabling access to our innovative medicines and diagnostic tests for New Zealanders, as well as providing support to patients and patient groups.

Patient groups are important partners for Roche, as we share an interest in ensuring patients have the support they need to manage their health together with their healthcare professionals.

Our work with patient groups aims to improve patients’ health and quality of life, as well as to ensure the quality use of Roche medicines. Additionally, as patient organisations represent the views of patients and their families on issues surrounding healthcare, they help shape the current and future healthcare environment by making their collective voices heard.

Roche collaborates with and provides support to a range of local patient groups in New Zealand and while doing so applies the principles of the  and our global  which focuses on the following set of principles: integrity independence, respect & equity, transparency, mutual benefit. Roche's current collaborations include Breast Cancer Aotearoa Coalition (BCAC), Sweet Louise, NZ Breast Cancer Foundation, Lung Foundation NZ, Multiple Sclerosis Society of NZ and Haemophilia Foundation of NZ.

© 2023, Roche Products (New Zealand) Ltd, Auckland. This site is intended for New Zealand audiences. Please be aware that we do not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or use in the country of your origin. Access to this site is subject to the terms in our Legal and Privacy Statement. You accept these terms by continuing to access this site.

M-NZ-00000625-v7.0/MR9618/DEC23. This site was last updated DEC2023